Last updated on January 2019

A Pragmatic Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study)


Brief description of study

A trial of patients with type 2 diabetes mellitus to evaluate the comparative effectiveness between dapagliflozin and Standard of Care (SOC)

Detailed Study Description

A longitudinal, open labelled, pragmatic randomized 104 week multicentre trial of patients with type 2 diabetes mellitus to evaluate the comparative effectiveness between dapagliflozin and Standard of Care (SOC)

Clinical Study Identifier: NCT02616666

Contact Investigators or Research Sites near you

Start Over

Research Site

Surrey, United Kingdom
  Connect »

Research Site

Guildford, United Kingdom
5.45miles
  Connect »

Research Site

Camberley, United Kingdom
8.02miles
  Connect »

Research Site

Farnborough, United Kingdom
8.54miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.